Abstract

Abstract Sixty‐two patients with fibromyalgia were randomly assigned to receive 25 mg of amitriptyline at night, 500 mg of naproxen twice daily, both amitriptyline and naproxen, or placebo in a 6‐week, double‐blind trial. Amitriptyline was associated with significant improvement in all outcome parameters, including patient and physician global assessments, patient pain, sleep difficulties, fatigue on awakening, and tender point score. Patients taking the combined naproxen—amitriptyline regimen experienced minor, but not significant, improvement in pain when compared with patients who took amitriptyline alone. Amitriptyline, or amitriptyline and naproxen, is an effective therapeutic regimen for patients with fibromyalgia.

Keywords

FibromyalgiaAmitriptylineNaproxenMedicineRandomized controlled trialInternal medicinePhysical therapyAlternative medicine

Affiliated Institutions

Related Publications

Publication Info

Year
1986
Type
article
Volume
29
Issue
11
Pages
1371-1377
Citations
443
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

443
OpenAlex

Cite This

Don L. Goldenberg, David T. Felson, Hal Dinerman (1986). A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis & Rheumatism , 29 (11) , 1371-1377. https://doi.org/10.1002/art.1780291110

Identifiers

DOI
10.1002/art.1780291110